43
Participants
Start Date
November 9, 2017
Primary Completion Date
February 5, 2019
Study Completion Date
February 5, 2020
Placebo
Placebo capsules that look like the 11β-MNTDC capsules but with no active ingredients.
11β-methyl-nortestosterone-dodecylcarbonate
11β-MNTDC doses in castor oil/benzyl benzoate capsules (100 mg each) administered in 200 mg or 400 mg doses orally.
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance
University of Washington Medical Center & Health Sciences, Seattle
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
OTHER
University of Washington
OTHER
Premier Research
OTHER